乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Cardiology >

PCI

News, opinions and meeting coverage in cardiology.

<乌鸦传媒>Time for Interventional Radiologists, Surgeons to End Turf War?

A look at two areas of contention: stenting, IVC filter implants

<乌鸦传媒>FDA Again Warns on Balloon Angioplasty for Neurologic Disorders

Says transvascular autonomic modulation is off-label and dangerous

<乌鸦传媒>Lotus Valve's Design Change Tied to Slowdown of PPM

Promising data for TAVR device undergoing a design rehaul

<乌鸦传媒>CRT: Physicians Squabble Over Tricuspid Valve Technologies

How low should tricuspid regurgitation go?

<乌鸦传媒>Subclavian TAVR Safe When Femoral Access Is Risky

Trial analysis shows similar morbidity, mortality

<乌鸦传媒>SAVR Beats Expectations in Intermediate Risk Trial

Lower mortality than surgical risk score predicted in PARTNER 2A

<乌鸦传媒>TAVR Workflow Checklists Released

Tools provide procedural framework, emphasize heart team approach

<乌鸦传媒>Cath Lab Recap: Killer Pacemakers; Heart Monitoring Underwear

Interventional cardiology news to note

<乌鸦传媒>After Tamponade, Pericardial Drain Removal Safe Once Dry

At one center, no advantage seen to keeping them in longer

<乌鸦传媒>AHA: Real World TAVR Is All About Patient Selection

Intermediate risk is a moving target

<乌鸦传媒>TCT: Orsiro No Better Than EES for CTO

Also, injectable collagenase eases PCI for CTO in trial

<乌鸦传媒>TCT: Amulet LAA Occluder Hot on the Heels of Watchman

Another LAA closure device shows favorable results in trial

<乌鸦传媒>TCT: Novel Drug-Coated Balloon Promising for Periphery

Stellarex beat angioplasty alone in fairly complex PAD population trial

<乌鸦传媒>Aneurysm Sealing Device Hits Hurdles

Migration, endoleaks, and aneurysm growth cited for novel Nellix device

<乌鸦传媒>TCT: TAVR Holds Up Pretty Well Over Time

Also, 2-year data confirm lasting improvements in QoL

<乌鸦传媒>TCT: For Heart Devices, Will Lag Moving from Europe to U.S. Wane?

FDA Commissioner and E.U. representative talk change

<乌鸦传媒>TCT: Trials Split on PCI vs CABG for Left Main Disease

NOBLE hands advantage to surgery, EXCEL finds noninferiority

<乌鸦传媒>TCT: Advantage of Novel DES Over BMS Grows With Time

For high bleeding risk patients, rationale for BMS continues to shrink

<乌鸦传媒>TCT: OCT Guidance Doesn't Undersize Stents, Trial Shows

Also found dissection, malapposition that IVUS missed

<乌鸦传媒>Pearls From: Roxana Mehran, MD

Interventional cardiologist discusses acute kidney injury reduction

<乌鸦传媒>ESC: Medical Therapy Adequate for Plaque Erosion

Pilot study suggests stenting not needed in uncomplicated cases

<乌鸦传媒>ESC: Winners Emerge in CAD Imaging Showdowns

Promising results for cardiac MRI, MPS, and PET

<乌鸦传媒>ESC: DES or BMS? No Mortality Difference

After 6 years, death was as likely in DES patients as in BMS patients

<乌鸦传媒>Afib: Poor Short-Term Outcomes More Common After Stenting

But where is that expected link between Afib and stroke?

<乌鸦传媒>Compression Stockings; Stroke Prevention; Stents and Meds

Cardiovascular Daily wraps up the top cardiology news of the week

<乌鸦传媒>EuroPCR: Staged Stenting Undermines SYNTAX II Strategy

Practice of unnecessary "re-touching" in the cath lab needs to go

<乌鸦传媒>EuroPCR: Absorbable Vascular Closure Device Safe

PerQseal data suggests 'progress' on large-bore PCI access closure

<乌鸦传媒>EuroPCR: TAVR Embolic Deflector May Cut Stroke Risk

Fewer, smaller CNS infarctions by some measures in pooled analysis

<乌鸦传媒>EuroPCR: Percutaneous Mitral Valves Face Stubborn Obstruction Risk

Mirroring early TAVR, the learning curve is still steep

<乌鸦传媒>EuroPCR: Watchman Safe in Real World Conditions

Inexperienced centers not less safe overall, international registry says

<乌鸦传媒>EuroPCR: Degenerated TAVR Not Uncommon by 10 Years

"Significant signal ... sooner than what we see in surgical valves

<乌鸦传媒>SCAI: No Early Sex Differences For TAVR

Bravo 3 substudy suggests benefit for women on bivalirudin, though

<乌鸦传媒>SCAI: Cell Tx May Be of Benefit for Refractory Angina

Standard of care toppled even as CD34+ investigation skids to a halt

<乌鸦传媒>Calculator May Cut Post Stent Bleeds

Small study suggests benefit

<乌鸦传媒>SCAI: Robots Can Do PCI -- They Just Take Longer

Is this the dawn of a new age for the cath lab?

<乌鸦传媒>10 Questions: Ilona J. Frieden, MD

'The structure of the system itself is the biggest barrier'

<乌鸦传媒>PAD Thrombectomy System Checks Out for Safety, Efficacy

No device-related adverse events in small arterial occlusion trial

<乌鸦传媒>ACC: No Benefit for Beta-Blocker Before PCI

IV metoprolol was safe, but disappointing

<乌鸦传媒>Embolism Halts Next-Gen Watchman in Europe

Cause still unknown, not expected to affect device sold in U.S.

<乌鸦传媒>ACC: After a Decade, CABG Pulls Ahead of Meds for HF

Life-saving benefit of CABG now clear in long-term trial follow-up

鈥�

16